Dispensing error legal change comes into effect

Dispensing error legal change comes into effect

April 16 2018 The amendment to the law which will give a defence to the criminal charge of making...

DHSC publishes review of impact of NHS pharmacy services changes introduced in 2013

DHSC publishes review of impact of NHS pharmacy services changes introduced in 2013

April 12 2018 Changes introduced in 2013 to manage pharmacy numbers, along with changes to the...

PSNC and NPA lobby for GDPR exemption for small primary care service providers

PSNC and NPA lobby for GDPR exemption for small primary care service providers

March 26 2018 Health organisations are asking that small NHS contractors be exempted from...

GPhC consultants on independent prescribing changes

GPhC consultants on independent prescribing changes

March 22 2018 The initial training and education of pharmacists studying to become independent...

Study questions appropriateness of 28-day prescriptions for long term conditions

Study questions appropriateness of 28-day prescriptions for long term conditions

March 22 2018 Medicine adherence may benefit in long term conditions by issuing prescriptions for...

  • Dispensing error legal change comes into effect

    Dispensing error legal change comes into effect

    Monday, 16 April 2018 14:06
  • DHSC publishes review of impact of NHS pharmacy services changes introduced in 2013

    DHSC publishes review of impact of NHS pharmacy services changes introduced in 2013

    Thursday, 12 April 2018 11:30
  • PSNC and NPA lobby for GDPR exemption for small primary care service providers

    PSNC and NPA lobby for GDPR exemption for small primary care service providers

    Monday, 26 March 2018 12:28
  • GPhC consultants on independent prescribing changes

    GPhC consultants on independent prescribing changes

    Thursday, 22 March 2018 11:55
  • Study questions appropriateness of 28-day prescriptions for long term conditions

    Study questions appropriateness of 28-day prescriptions for long term conditions

    Thursday, 22 March 2018 11:44

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

pills4June 27 2016

Guidance on naloxone supply has been updated with advice about what to consider when there is a need for use in people under 18 years.

The guidelines were introduced in October 2015 as part of a move to widen the availability of naloxone as an emergency antidote for overdoses caused by heroin and other opiates or opioids such as methadone and morphine.

They are intended for use by drug treatment services authorised to supply naloxone, including:

  • drug services commissioned from primary care providers
  • drug services commissioned from secondary care providers (including a range of specialised community and inpatient drug services)
  • commissioned services providing needle and syringe programmes (including those provided from pharmacies)
  • pharmacies providing drug treatment services.

The update says that “any drug treatment service considering providing a child or young person under 18 with training on overdose management or on the use of naloxone, or considering direct supply of naloxone, should always act in line with established clinical principles for the treatment of children and young people.

“This is the case whether the goal of such consideration is to reduce risks to a young person who is using drugs or to reduce risk for others (such as an opioid-using parent).”

It points out that there are no legal restrictions under the 2015 legislation, and that “such a decision would need very careful consideration and oversight and would need to be made on a case by case basis.

“An appropriately competent professional acting within a suitable clinical governance framework would have to consider the needs of each child or young person, taking account of potential benefits to the child of the intervention and any risks.”

Factors they would need to take into account include the child or young person’s ability to understand the issues involved and to provide suitable consent. “In the case of a child who exercises a carer role for a drug-using parent, consideration of the interests of the child can be quite complex.” There is also a need to consider issues such as those relating to child safeguarding.

Links:

Department of Health Guidance

Updated guidance

Legal & Policy News

April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...
April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...